Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · June 26, 2023

Angiographic Biomarkers Significantly Predict Treatment Response to Intravitreal Aflibercept in Patients With Diabetic Macular Edema

Scientific Reports

 

Additional Info

Scientific Reports
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
Sci Rep 2023 May 19;13(1)8128, M Hein, A Vukmirovic, IJ Constable, V Raja, A Athwal, KB Freund, C Balaratnasingam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading